牛牛AI助理已提取核心訊息
In a recent transaction, Robin Toft, a reporting person for T2 Biosystems, Inc. [TTOO], engaged in a stock market action on January 1, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Additionally, the relationship of Robin Toft to the issuer, T2 Biosystems, was not specified. The transaction's status, whether it was a purchase, sale, or another type of action, was also not provided in the available information.
In a recent transaction, Robin Toft, a reporting person for T2 Biosystems, Inc. [TTOO], engaged in a stock market action on January 1, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Additionally, the relationship of Robin Toft to the issuer, T2 Biosystems, was not specified. The transaction's status, whether it was a purchase, sale, or another type of action, was also not provided in the available information.
在最近的一筆交易中，T2 Biosystems, Inc. [TTOO] 的舉報人羅賓·托夫特於2024年1月1日參與了股市交易。該交易的具體細節，包括所涉及的股票數量、股票的性質、交易價格和股票的總價值，未在公告中披露。此外，沒有具體說明羅賓·托夫特與發行人T2 Biosystems的關係。現有信息中也沒有提供該交易的狀態，無論是購買、出售還是其他類型的行動。
在最近的一筆交易中，T2 Biosystems, Inc. [TTOO] 的舉報人羅賓·托夫特於2024年1月1日參與了股市交易。該交易的具體細節，包括所涉及的股票數量、股票的性質、交易價格和股票的總價值，未在公告中披露。此外，沒有具體說明羅賓·托夫特與發行人T2 Biosystems的關係。現有信息中也沒有提供該交易的狀態，無論是購買、出售還是其他類型的行動。
有用
沒用